Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress and regression within primary Sjögren's syndrome.

R Manthorpe1, A Bredberg, G Henriksson

  • 1Outpatients Department, Sjögren's Syndrome Research Centre, Malmö, Sweden. Manthorpe@inet.uni2.dk

Scandinavian Journal of Rheumatology
|February 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A wide spectrum of fastidious and ampicillin-susceptible bacteria dominate in animal-caused wounds.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
Same author

Heterogeneity among septic shock patients in a set of immunoregulatory markers.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2013
Same author

Wnt5a inhibits human monocyte-derived myeloid dendritic cell generation.

Scandinavian journal of immunology·2013
Same author

TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls.

The European respiratory journal·2011
Same author

Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.

British journal of pharmacology·2008
Same author

Sjogren's syndrome and the danger model.

Rheumatology (Oxford, England)·2005

Primary Sjögren

Area of Science:

  • Rheumatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Primary Sjögren's syndrome (SS) is a prevalent autoimmune rheumatic disease.
  • Research interest has grown, yet funding remains disproportionately low compared to rheumatoid arthritis (RA).
  • SS continues to be under-diagnosed, under-treated, and under-researched.

Purpose of the Study:

  • To provide a contemporary overview of key aspects of primary Sjögren's syndrome.
  • To update knowledge on clinical manifestations, pathogenesis, etiology, treatment, and prognosis.
  • To highlight areas requiring further investigation and research focus.

Main Methods:

  • Literature review focusing on recent advancements and established knowledge.
  • Synthesis of information on clinical features, diagnostic criteria, and prognostic indicators.

Related Experiment Videos

  • Exploration of pathogenetic mechanisms, including the Danger model and IgG4-related pathology.

    • Main Results:

    • Clinical manifestations encompass a range of signs and symptoms, with specific predictors for non-Hodgkin malignant lymphoma (NHML).
    • Current treatment strategies and prognostic factors are reviewed.
    • The Danger model offers insights into aetiopathogenesis, alongside the role of immunoglobulin G4 (IgG4)-positive cells in pathology.

    Conclusions:

    • Primary Sjögren's syndrome warrants increased research attention and funding.
    • A comprehensive understanding of its clinical, pathogenetic, and pathological facets is crucial for improved patient outcomes.
    • Further research is needed to address the under-diagnosis and under-treatment of SS.